MGTX,MeiraGTx Holdings plc | Healthcare

Healthcare

MGTX

All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities

MeiraGTx Holdings plcMGTX

USD

- At close

USD

- Until the end

The complete list of US stocks

MAX

Overview >

% Change

Description >

MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases.

The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases, neurodegenerative diseases, and xerostomia.

Its programs in clinical development include Phase I/II clinical stage programs in achromatopsia, X-linked retinitis pigmentosa, and RPE65-deficiency; Phase I clinical trials for radiation-induced xerostomia; and Parkinson's program that has completed a Phase II trial.

It has a research collaboration agreement with Janssen Pharmaceuticals, Inc. for the research, development, and commercialization of gene therapies for the treatment of inherited retinal disease.

MeiraGTx Holdings plc was incorporated in 2015 and is based in New York, New York.

Latest News >

'Agatha All Along' crafts a witch coven community run by women

Sep 17, 2024

LOS ANGELES, Sept 17 (Reuters) - Actor Kathryn Hahn met with a person she describes as a real-life witch every week to help her further embrace her role as the witch Agatha Harkness in the show Agatha All Along. Her mission was to try to de-trope what we see as witches and really add the aspect of community and nature,...

EA confident about annual bookings, announces new 'Battlefield' title

Sep 17, 2024

Sept 17 (Reuters) - Videogame publisher Electronic Arts ( EA ) said it expects to achieve the high end of its annual bookings forecast and unveiled the next installment of its multi-player shooter game Battlefield at its investor day conference on Tuesday. The new title will mark a return to the modern-day setting, after three consecutive games set in different...

Microsoft and BlackRock plan $30 bln fund to invest in AI infrastructure, FT reports

Sep 17, 2024

Sept 17 (Reuters) - BlackRock ( BLK ) is preparing to launch a more than $30 billion artificial intelligence investment fund with Microsoft ( MSFT ) to build data centers and energy projects to meet growing demands stemming from AI, the Financial Times reported on Tuesday, citing people briefed about the matter. ...

Kadant Insider Sold Shares Worth $3,223,496, According to a Recent SEC Filing

Sep 17, 2024

04:09 PM EDT, 09/17/2024 (MT Newswires) -- Jeffrey L Powell, Director, President & CEO, on September 13, 2024, sold 10,000 shares in Kadant ( KAI ) for $3,223,496. Following the Form 4 filing with the SEC, Powell has control over a total of 48,667 shares of the company, with 48,667 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/886346/000088634624000142/xslF345X05/wk-form4_1726603388.xml Price: 333.65, Change: -0.27,...